The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMutlu, Hasan
dc.contributor.authorArslan, Deniz
dc.contributor.authorGunduz, Seyda
dc.contributor.authorTural, Deniz
dc.contributor.authorBuyukcelik, Abdullah
dc.contributor.authorCihan, Yasemin Benderli
dc.contributor.authorAslan, Tuncay
dc.contributor.authorBozcuk, Hakan
dc.contributor.authorCoskun, Hasan Senol
dc.date.accessioned2025-10-16T15:33:28Z
dc.date.issued2014
dc.identifier.doi10.1159/000371414
dc.identifier.otherWOS:000351614400006
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9253
dc.publisherKARGER
dc.sourceCHEMOTHERAPY
dc.subjectLung cancer
dc.subjectTreatment
dc.subjectChemotherapy
dc.subjectInduction
dc.subjectConsolidation
dc.titleThe Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS